2Firsts Talks with Nancy Loucas, Asia-Pacific THR Leader: Giving a Voice to the Overlooked Consumer

Jun.18.2025
Ahead of the upcoming Global Forum on Nicotine (GFN), 2Firsts interviews Nancy Loucas, Executive Coordinator of CAPHRA, on why consumers must have a voice in tobacco harm reduction policymaking—and how she’s helping them speak up.

[By Taco Tuinstra | 2Firsts] Nancy Loucas: Helping Consumers Find Their Voice

 

As part of its media partnership with the Global Forum on Nicotine (GFN), scheduled for June 19-21 in Warsaw, 2Firsts reached out to several scheduled speakers, and asked them about their respective fields of expertise.

 

Nancy Loucas has been fighting for vapers’ rights to be able to access the tools they need to become smokefree and remain smoke free since 2015, when she co-founded the Aotearoa Vapers Community Advocacy in New Zealand.

 

She is also the executive director of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), which supports consumer tobacco harm reduction (THR) advocacy organizations and activities throughout the Asia Pacific region and beyond.

 

Under Loucas’ leadership, CAPHRA established numerous initiatives to give a voice to the consumer, who she says is often overlooked in the debates. Such programs include the “Right2Vape” testimonial database (set up in collaboration with the Consumer Advocates for Smoke-free Alternatives Association in the United States) and the “Right2Switch” petition, which urges the World Health Organization to regulate based on science and include consumers into its decision-making process.

 

At the GNF, Loucas will be hosting a workshop to help consumers effectively communicate their message, which fits well with the overall conference theme of “Challenging Perceptions – Effective Communication for Tobacco Harm Reduction.” 2Firsts asked Loucas about her aspirations and the challenges facing consumers.

 

2Firsts Talks with Nancy Loucas, Asia-Pacific THR Leader: Giving a Voice to the Overlooked Consumer

Nancy Loucas | Image: AVCA

 

2Firsts: What inspired you to become a consumer advocate in the THR field?

 

Loucas: Watching relatives become ill and eventually die from smoking-related diseases. Watching relatives not receive appropriate medical care for nonsmoking-related illnesses, because of their smoking status. Not wanting my children to lose their mother, as I lost mine from smoking, at an early age. Wanting others to have the same opportunity I had to move off the deadly stuff.

 

2Firsts: How do you define THR, and why is the consumer perspective essential in this space?

 

Loucas: Short answer: My definition of THR is saving lives with innovation. Long answer: It is the prevention of smoking related death and disease through the use of innovative nicotine products that help people to move away from smoking and unsafe oral tobacco use.

 

2Firsts: What challenges do consumers face in communicating their positions?

 

Loucas: The main challenge is being listened to. The Machine, as I like to call tobacco control, likes to denigrate and dehumanize consumers and their lived experiences by labeling them as “anecdotes,” as opposed to scientists, experts or researchers. They do this by calling us names, accusing us of nefarious activities to the benefit of tobacco companies, and [by] excluding us from a seat at the table.

 

Another challenge arises from external NGO's [nongovernmental organizations] coming into countries without actually caring about that country, its culture or its problems, but only wanting to control the narrative with their views, their solutions, their policies. In Asia Pacific, a western mindset doesn't translate well at all.

 

2Firsts:What strategies have you found effective in elevating consumer perspectives in regulatory or scientific arenas?

 

Loucas:The one really good thing about the wider THR community is that the consumers, scientists and some regulatory people do communicate with respect and consideration. At conferences, everyone engages; the pro-THR scientists treat the consumers as equals.

 

In Asia Pacific—with the exception of Australia and India—there's less of a barrier between advocates on the one hand and public health and/or government on the other. That could be due to a number of factors, but I think it's mainly about networking in collective societies. Asia Pacific folks aren't very individualistic and going on about “my rights as an individual.” There are consumers who are on government committees about regulation; there are consumers who regularly engage with regulatory folks on a personal level.

 

The elevation of the consumer perspective is not so much the issue as is the backlash and misinformation from externally funded tobacco control-NGOs pushing a scripted narrative.

 

2Firsts:In your view, how can consumers be meaningfully involved in policy development on nicotine and tobacco products?

 

Loucas:Consumers can be—and should be—meaningfully involved in policy development as the decisions made directly impact them. The best way to do that is to engage. Some consumers are afraid they do not have the skills or the “right” to speak to policy/public health/government people, but with some support, some training and focus, they are the kingmakers really. My main comment to consumers who are reticent to engage is this "elected officials work for you, not the other way around.”

 

2Firsts:What are the primary benefits you hope participants will gain from your GFN workshop?

 

Loucas:The GFN is about learning, community and support. The workshop is about helping people succeed in their advocacy and feel supported and confident in their mission.

 

2Firsts has been a media partner of the Global Forum on Nicotine (GFN) for three consecutive years.


2Firsts welcomes article submissions, interview opportunities, or commentary. Please contact us at info@2firsts.com or connect with 2Firsts CEO Alan Zhao on LinkedIn here.

 

COP11 Concludes with Major Decisions on Global Tobacco Control
COP11 Concludes with Major Decisions on Global Tobacco Control
The Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on November 22, with 160 Parties adopting major decisions on tobacco and nicotine regulation, environmental protection, sustainable financing, and tobacco industry liability. A landmark decision mandates a complete ban on the use and sale of tobacco and all novel nicotine products across all UN premises worldwide.
Nov.24 by 2FIRSTS.ai
Lancet Study Finds Rising Use of Nicotine Pouches in Britain
Lancet Study Finds Rising Use of Nicotine Pouches in Britain
A study published in The Lancet has found that nicotine pouch use is increasing in Britain, particularly among young men. Usage among people aged 16 to 24 has risen sharply since early 2022.
Dec.17 by 2FIRSTS.ai
Kenya Court of Appeal Halts BBC Defamation Case Linked to BAT Bribery Documentary
Kenya Court of Appeal Halts BBC Defamation Case Linked to BAT Bribery Documentary
Kenya’s Court of Appeal has paused the defamation proceedings filed by National Assembly Speaker Moses Wetang’ula against the BBC. The case centers on a 2015 BBC documentary, Panorama: The Secret Bribes of Big Tobacco, which alleged that Wetang’ula received unlawful benefits from British American Tobacco (BAT) during his tenure as a senator.
Dec.02 by 2FIRSTS.ai
SKE Partners with 7-Eleven Korea, Placing Its Products in Over 5,700 Stores
SKE Partners with 7-Eleven Korea, Placing Its Products in Over 5,700 Stores
According to an SKE release published on PR Newswire, the company is expanding its presence in the Korean market through convenience store and specialty retail channels. SKE has partnered with 7-Eleven Korea, placing its products in more than 5,700 stores nationwide, and is also working with OG9’s offline retail and B2B distribution network. On the product side, SKE is focusing on promoting the Crystal Bar TB1000 and Cloud Zero in Korea.
Nov.19 by 2FIRSTS.ai
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20
BAT Taps McLaren Title Win for Travel Retail Activation, Launches VELO “Champions’ Edition” Nicotine Pouches
BAT Taps McLaren Title Win for Travel Retail Activation, Launches VELO “Champions’ Edition” Nicotine Pouches
British American Tobacco (BAT) is leveraging McLaren F1 Team’s 2025 Constructors’ Championship win to roll out a VELO×McLaren brand activation across the travel retail market. The campaign spans major airports in Abu Dhabi, the UK, Ireland and Spain, alongside the launch of a VELO “Champions’ Edition” product.
Dec.15 by 2FIRSTS.ai